Replies to post #211968 on Biotech Values

[DewDiligence]

MNTA—Reiterating FDA comment on interchangeable FoBs:

http://raps.org/Regulatory-Focus/News/2017/06/26/27969/FDA-Interchangeable-Biosimilar-Approvals-Expected-Within-2-Years/

…FDA’s biosimilars lead Leah Christl said last week at DIA’s annual conference in Chicago that she expects interchangeable biosimilars will come to market within the next two years, though possibly sooner.